ストックスクリーナーアプリを入手
90.44
0.54%
-0.57
前日終値:
$91.01
開ける：
$91
24時間の取引高:
49,876
Relative Volume:
0.12
時価総額：
$1.96B
収益：
$486.82M
当期純損益:
$18.78M
株価収益率:
110.29
EPS:
0.82
ネットキャッシュフロー:
$100.45M
1週間 パフォーマンス:
+0.90%
1か月 パフォーマンス:
+34.14%
6か月 パフォーマンス:
+66.06%
1年 パフォーマンス:
+46.76%
1日の値動き範囲:
$89.81
$92.65
1週間の範囲:
$88.82
$92.65
52週間の値動き範囲:
$52.50
$92.65
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
名前
Ani Pharmaceuticals Inc
セクター
電話
(218) 634-3500
住所
210 MAIN STREET WEST, BAUDETTE, MN
ANIP を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
90.53 | 1.95B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
155.52 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.21 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.705 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.41 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
308.54 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 開始されました | H.C. Wainwright | Buy |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-03-12 | 開始されました | JP Morgan | Overweight |
| 2024-12-11 | 開始されました | Leerink Partners | Outperform |
| 2024-10-11 | 開始されました | Piper Sandler | Overweight |
| 2024-03-15 | 開始されました | CapitalOne | Overweight |
| 2023-08-22 | 繰り返されました | H.C. Wainwright | Buy |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2022-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-02 | 開始されました | Truist | Buy |
| 2020-05-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | 開始されました | Guggenheim | Buy |
| 2019-05-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | 繰り返されました | Canaccord Genuity | Buy |
| 2017-07-31 | 開始されました | Canaccord Genuity | Buy |
| 2017-02-22 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2016-06-23 | 開始されました | Raymond James | Strong Buy |
| 2016-05-24 | ダウングレード | Standpoint Research | Buy → Hold |
| 2015-11-13 | 開始されました | Standpoint Research | Buy |
| 2015-09-28 | アップグレード | ROTH Capital | Neutral → Buy |
| 2015-08-05 | 繰り返されました | Oppenheimer | Outperform |
| 2015-08-04 | 繰り返されました | ROTH Capital | Neutral |
| 2015-07-31 | 繰り返されました | Oppenheimer | Outperform |
| 2015-07-15 | 繰り返されました | ROTH Capital | Neutral |
| 2015-06-23 | 繰り返されました | Oppenheimer | Outperform |
| 2015-05-18 | 繰り返されました | ROTH Capital | Neutral |
| 2015-05-06 | 繰り返されました | Oppenheimer | Outperform |
| 2015-04-10 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2015-02-26 | 繰り返されました | ROTH Capital | Buy |
| 2015-02-18 | 繰り返されました | Oppenheimer | Outperform |
すべてを表示
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
MACD Signals Flash Warning for ANI Pharmaceuticals Inc. StockMarket Performance Recap & Fast Entry High Yield Tips - newsyoung.net
Ani Pharmaceuticals stock hits 52-week high at 90.43 USD By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals Executives Sell Shares Amid Market Volatility - AInvest
ANI Pharmaceuticals' Insider Sales: Strategic Liquidity or a Warning Signal for Shareholders? - AInvest
Insider Selling at ANI Pharmaceuticals: A Cautionary Signal Amidst Strong Earnings and Analyst Optimism? - AInvest
Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock - Investing.com
Ani Pharmaceuticals Insider Sold Shares Worth $801,450, According to a Recent SEC Filing - MarketScreener
Shanmugam Muthusamy of Ani Pharmaceuticals sells $8.8m in stock By Investing.com - Investing.com UK
Ani Pharmaceuticals stock hits 52-week high at 90.43 USD - Investing.com India
Momentum Screeners Rank ANI Pharmaceuticals Inc. in Top 5 Today2025 Institutional Moves & Real-Time Volume Analysis Alerts - classian.co.kr
Will ANI Pharmaceuticals Inc. Hold Gains Into CloseMarket Weekly Review & Consistent Income Trade Ideas - newsimpact.co.kr
ANI gets FDA approval for generic Motegrity - MSN
ANI Pharmaceuticals, Berkshire Hathaway, Chevron - TradingView
Using R and stats models for ANI Pharmaceuticals Inc. forecastingStop Loss & Weekly Top Gainers Trade List - Newser
Advanced analytics toolkit walkthrough for ANI Pharmaceuticals Inc.Market Performance Recap & Real-Time Sentiment Analysis - Newser
ANI Pharmaceuticals Inc. stock daily chart insights2025 Support & Resistance & Risk Managed Investment Strategies - Newser
Published on: 2025-08-17 01:40:35 - Newser
ANI Pharmaceuticals Inc. stock outlook for YEAR2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Trend analysis for ANI Pharmaceuticals Inc. this weekWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
This Insider Has Just Sold Shares In ANI Pharmaceuticals - simplywall.st
ANI Pharmaceuticals Inc.’s Price Action Aligns with Quant SignalsConsistent High Return Strategy - beatles.ru
Technical signs of recovery in ANI Pharmaceuticals Inc.July 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Upgraded by Wall Street Zen - Defense World
Assessing Insider Selling at ANI Pharmaceuticals: Confidence or Concern? - AInvest
Chart based exit strategy for ANI Pharmaceuticals Inc.July 2025 PostEarnings & AI Based Buy/Sell Signal Reports - Newser
Nikhil Lalwani Sells 56,960 Shares of ANI Pharmaceuticals Inc, Insider Now Owns 411,219 Shares - AInvest
Leerink Partners Maintains Buy Rating on ANI Pharmaceuticals with $100 Price Target - AInvest
ANI Pharmaceuticals Inc. recovery potential after sell offJuly 2025 Setups & Entry and Exit Point Strategies - Newser
ANI Pharmaceuticals' Insider Sale: A Strategic Warning or a Misread Opportunity? - AInvest
The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
Can ANI Pharmaceuticals Inc. Overcome Bearish SentimentBear Alert & Smart Allocation Stock Reports - sundaytimes.kr
Nikhil Lalwani, president of ANI Pharmaceuticals, sells $4.89m in stock - Investing.com Nigeria
Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals SVP, Gutwerg, sells $508,190 in stock - Investing.com
ANI Pharmaceuticals director Haughey sells $1.66 million in stock - Investing.com
Ani Pharmaceuticals SVP Carey sells $4.3m in shares By Investing.com - Investing.com Australia
Ani Pharmaceuticals’ Cook sells $35k in stock - Investing.com
Ani Pharmaceuticals SVP Carey sells $4.3m in shares - Investing.com India
Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock - Investing.com India
ANI Pharmaceuticals director Haughey sells $1.66 million in stock By Investing.com - Investing.com Canada
Rowland, SVP at Ani Pharmaceuticals, sells $426k in stock By Investing.com - Investing.com Australia
ANI Pharmaceuticals' Insider Sales: Liquidity or Lack of Confidence? - AInvest
Insider Selling at ANI Pharmaceuticals: Liquidity Moves or Lack of Confidence? - AInvest
Council approves plans for pharmaceutical manufacturing facility - veronapress.com
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript - MSN
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know - Yahoo Finance
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
ANI Pharmaceuticals Inc. Surpasses Analyst Target Price of $83.12 - AInvest
Ani Pharmaceuticals Inc (ANIP) 財務データ
収益
当期純利益
現金流量
EPS
Ani Pharmaceuticals Inc (ANIP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Leonard Matthew J | Director |
Aug 18 '25 |
Sale |
88.17 |
6,937 |
611,635 |
9,392 |
| Walsh Patrick D | Director |
Aug 15 '25 |
Sale |
89.05 |
9,000 |
801,450 |
70,048 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS |
Aug 15 '25 |
Sale |
87.15 |
52,990 |
4,618,078 |
531,920 |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS |
Aug 14 '25 |
Sale |
89.48 |
47,010 |
4,206,455 |
584,910 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY |
Aug 15 '25 |
Sale |
86.97 |
20,000 |
1,739,400 |
173,226 |
1.55%
大文字化:
|
ボリューム (24 時間):